CCHT(SZ:000661)2022-12-07 09:08Funding and Financial Strategy - The company plans to raise CNY 1.4 billion for working capital to support product development and marketing channel construction [1] - The choice of rights issue for refinancing is due to its relatively convenient approval process, which helps meet funding needs efficiently [2] Investment Strategy - The company focuses on the health industry, aiming to invest in high-tech products and high-growth sectors [3] - A new corporate development department has been established to select and evaluate industry projects, leveraging experienced intermediaries for project sourcing [4] Project Development and Sales Channels - The company is interested in cutting-edge biotechnologies, including cell therapy, but is awaiting technology validation before proceeding with specific projects [5] - Progress is ongoing in building sales channels, with a team of professionals being developed and specific plans under evaluation [6] Project Funding and Management - The company will not wait for the rights issue funds to be in place before advancing mature projects, utilizing its own funds or other financing methods instead [7] - The management is optimistic about achieving the operational targets set by the board, with expected profit growth not lower than the industry average [8]